New Jersey recently made changes to what is known as the Mansion Tax. New Jersey imposes an additional tax on the transfer of certain types of real estate when the sales price exceeds $1 million. Until recently, that tax was 1%. Under new legislation, that tax is now between 1% and 3.5%, depending on the sales price.
Owners of Class 4A commercial real estate have not been able to escape this tax by transferring an entity that owns real estate rather than the real estate itself. Instead of being called the Mansion Tax, this tax is called the Controlling Interest Transfer Tax (CITT).
What Are the Changes?
The new bill (P.L. 2025, c. 69) adds four more tiers as follows:
Sale Price
CITT
$1 million to $2 million
1.0%
Over $2 million to $2.5 million
2.0%
Over $2.5 million to $3 million
2.5%
Over $3 million to $3.5 million
3.0%
Over $3.5 million
3.5%
Need to Know
The new law makes it clear that the tax is imposed on the seller of the property. The new tax applies to real estate contracts executed on or after July 10, 2025. For the tax NOT to apply, the contract would have had to have been executed before July 10, 2025, AND the deed must be recorded prior to November 15, 2025.
These rules apply to Class 4A commercial property owned by an entity. There are more rules and details that may have to be considered, depending on the nature of your transaction.
A Look Back at Key 2025 Changes to Delaware Corporation Law
Senate Bill 21 This bill was enacted largely in response to high-profile litigation, such as In re Match Group (In re Match Grp., Inc. Deriv. Litig., 315 A.3d 446 (Del. 2024)) and TripAdvisor (Maffei v. Palkon, 2025 WL 384054 (Del. Feb. 4, 2025)) and to stem the recent tide of Delaware companies reincorporating in Neveda […]
New York Corporate Transparency Act: What You Need to Know for 2026
The New York Corporate Transparency Act (NYCTA) WILL NOT apply to US-registered LLCs. In recent years, there has been significant interest in identifying the “beneficial owners” of U.S. businesses to combat perceived financial crimes such as money laundering, terrorism financing, and tax fraud by ending the use of anonymous shell companies. This led to the […]
Executive Order Accelerates Federal Cannabis Rescheduling and Expands Medical Marijuana and Cannabinoid Research
On December 18, 2025, President Donald Trump signed an Executive Order titled Increasing Medical Marijuana and Cannabidiol Research, marking the most consequential federal cannabis policy action in decades. While the Order does not legalize marijuana or immediately alter its status under federal law, it directs the administration to complete the long-anticipated rescheduling of cannabis under […]
Strict Compliance Is Necessary: NJ Public Bidding Dispute Offers Lessons for Public Entities and Contractors
In ML, Inc. v. Edison Township Board of Education, the New Jersey Appellate Division reinforced the discretion of public entities to draft and enforce timing requirements as to the dates of key bid forms that are required to be submitted with public bids. The court upheld the Edison Township Board of Education’s decision to award a […]
NJDEP Reproposes All Appropriate Inquiry (AAI) Due Diligence Discharge Reporting Rule: Key Implications
On November 17, 2025, the New Jersey Department of Environmental Protection (NJDEP) changed its previously proposed rule which would have required persons conducting All Appropriate Inquiry (AAI)(due diligence) at real properties to report any discharge of contamination discovered during the due diligence to NJDEP and the record owner of the property. NJDEP has now changed […]
Federal Cannabis Rescheduling: Status, Impacts, and Strategies
Recent reports indicate that President Trump is preparing to issue an executive order as early as Monday, December 15 directing his administration to finalize the long-anticipated reclassification of cannabis under the federal Controlled Substances Act (CSA) from Schedule I to Schedule III. This development follows years of regulatory review and political debate spanning multiple administrations […]
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Sign up to get the latest from our attorneys!
Explore What Matters Most to You.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!
